News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Are you a tool developer who wants to apply your skills to support cancer research? Register for this challenge by Monday, November 25, and you’ll be on your way to developing an analysis tool for integrating with NCI’s Genomic Data Commons.

If you’re working with NIH genomic data, you’ll need to be aware of some new security requirements for data management and access that take effect on January 25, 2025. Learn more about how this could impact your work.

With the help of machine learning, NCI-funded researchers were able to boost the prognostic power of a common blood test for liver cancer.

Want to identify existing gene mutations more accurately and discover new signatures more efficiently? There’s a new NCI-funded tool, the Mutational Signature Calculator, that can help improve your standard workflow.

Are you having trouble prioritizing which genetic variants to study in your cancer research? There’s a new platform, called FORGEdb, that can help you pinpoint promising variants and target genes.

Interested in blending clinical and genetic data? Upgrades in cBioPortal can help you work with these very different data types to better understand cancer and how it progresses over time.

Do you conduct research on statistical and analytical methods, cancer survivorship, digital health, and/or data science tools and methods? Apply for an R01 grant from NCI’s Division of Cancer Control and Population Sciences by June 5 or October 5, 2024.

What if you could predict how a chemotherapy drug would work—in terms of sensitivity and side-effects—before you ever use it? NCI-funded researchers are using machine learning models to better understand a key mechanism underlying cancer, giving us new ways to predict responses to common chemotherapy drugs.

This Notice of Funding Opportunity will allow you to create and run a short course to educate early career researchers on using data sets available in NIH’s Common Fund.

NCI-funded researchers are using a machine learning approach to predict cancer outcomes based on epigenetic data, which take into account both environmental and genetic influences.